A detailed history of China Universal Asset Management Co., Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,935 shares of MGNX stock, worth $50,127. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,935
Previous 11,935 -0.0%
Holding current value
$50,127
Previous $176,000 0.57%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$9.77 - $21.47 $46,514 - $102,218
4,761 Added 66.36%
11,935 $176,000
Q4 2023

May 21, 2024

SELL
$4.48 - $10.11 $21,329 - $48,133
-4,761 Reduced 39.89%
7,174 $69,000
Q4 2023

Jan 23, 2024

BUY
$4.48 - $10.11 $24,984 - $56,383
5,577 Added 349.22%
7,174 $69,000
Q3 2023

May 21, 2024

BUY
$4.48 - $6.19 $3,521 - $4,865
786 Added 96.92%
1,597 $7,000
Q3 2023

Oct 30, 2023

BUY
$4.48 - $6.19 $3,521 - $4,865
786 Added 96.92%
1,597 $7,000
Q2 2023

May 21, 2024

SELL
$4.62 - $7.54 $101 - $165
-22 Reduced 2.64%
811 $4,000
Q2 2023

Jul 27, 2023

SELL
$4.62 - $7.54 $101 - $165
-22 Reduced 2.64%
811 $4,000
Q1 2023

May 21, 2024

BUY
$4.82 - $7.24 $1,007 - $1,513
209 Added 33.49%
833 $5,000
Q1 2023

Apr 27, 2023

BUY
$4.82 - $7.24 $1,007 - $1,513
209 Added 33.49%
833 $6,000
Q4 2022

May 21, 2024

SELL
$5.62 - $6.98 $63,567 - $78,950
-11,311 Reduced 94.77%
624 $4,000
Q4 2022

Jan 31, 2023

BUY
$5.62 - $6.98 $275 - $342
49 Added 8.52%
624 $4,000
Q3 2022

Oct 21, 2022

BUY
$3.01 - $5.22 $1,730 - $3,001
575 New
575 $2,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $258M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.